These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14963406)

  • 21. [Docetaxel (TXT) and irinotecan (CPT-11) as a second-line chemotherapy for platinum-pretreated squamous cell carcinoma of the head and neck].
    Sakoda T; Morizane R; Nosaka A; Nakahara K; Fukutsuji K; Yamanishi M; Ikeda H; Shibano A; Enomoto T; Kitano H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1311-4. PubMed ID: 18701840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model.
    Joschko MA; Webster LK; Groves J; Yuen K; Palatsides M; Ball DL; Millward MJ
    Radiat Oncol Investig; 1997; 5(2):62-71. PubMed ID: 9303059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
    Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
    Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells.
    Huang Y; Hager ER; Phillips DL; Dunn VR; Hacker A; Frydman B; Kink JA; Valasinas AL; Reddy VK; Marton LJ; Casero RA; Davidson NE
    Clin Cancer Res; 2003 Jul; 9(7):2769-77. PubMed ID: 12855657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ).
    Pradier O; Rave-Fränk M; Lehmann J; Lücke E; Boghun O; Hess CF; Schmidberger H
    Int J Cancer; 2001 Mar; 91(6):840-5. PubMed ID: 11275989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of Dual Oxidase 2 (DUOX2) to Hyper-Radiosensitivity in Human Gastric Cancer Cells.
    Nguyen DM; Parekh PR; Chang ET; Sharma NK; Carrier F
    Radiat Res; 2015 Aug; 184(2):151-60. PubMed ID: 26207686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HER2-antibody enhances irradiation-induced growth inhibition in head and neck carcinoma.
    Uno M; Otsuki T; Kurebayashi J; Sakaguchi H; Isozaki Y; Ueki A; Yata K; Fujii T; Hiratsuka J; Akisada T; Harada T; Imajo Y
    Int J Cancer; 2001 Nov; 94(4):474-9. PubMed ID: 11745431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of cyclin D1-cdk5 overexpression and MCM3 cleavage in bax-associated spontaneous apoptosis and differentiation in an A253 human head and neck carcinoma xenograft model.
    Yin MB; Tóth K; Cao S; Guo B; Frank C; Slocum HK; Rustum YM
    Int J Cancer; 1999 Oct; 83(3):341-8. PubMed ID: 10495426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer activity of docetaxel in murine salivary gland carcinoma.
    Piechocki MP; Lonardo F; Ensley JF; Nguyen T; Kim H; Yoo GH
    Clin Cancer Res; 2002 Mar; 8(3):870-7. PubMed ID: 11895921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer.
    Allal AS; Zwahlen D; Becker M; Dulguerov P; Mach N
    Cancer J; 2006; 12(1):63-8. PubMed ID: 16613664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck.
    Fujii M; Tsukuda M; Satake B; Kubota A; Kida A; Kohno N; Okami K; Inuyama Y;
    Int J Clin Oncol; 2004 Apr; 9(2):107-12. PubMed ID: 15108042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The growth inhibiting effect of docetaxel (Taxotere) in head and neck squamous cell carcinoma xenografts.
    Braakhuis BJ; Kegel A; Welters MJ
    Cancer Lett; 1994 Jun; 81(2):151-4. PubMed ID: 7912164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts.
    Helbig L; Koi L; Brüchner K; Gurtner K; Hess-Stumpp H; Unterschemmann K; Baumann M; Zips D; Yaromina A
    Radiat Oncol; 2014 Sep; 9():207. PubMed ID: 25234922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
    Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
    Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.
    Newell M; Goruk S; Mazurak V; Postovit L; Field CJ
    Breast Cancer Res Treat; 2019 Sep; 177(2):357-367. PubMed ID: 31236812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation.
    Zeitlin BD; Spalding AC; Campos MS; Ashimori N; Dong Z; Wang S; Lawrence TS; Nör JE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):879-87. PubMed ID: 20675079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.
    Rupnow BA; Murtha AD; Alarcon RM; Giaccia AJ; Knox SJ
    Cancer Res; 1998 May; 58(9):1779-84. PubMed ID: 9581811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.